Title: Senate Appropriations Committee Hearing: Addressing Vaccine Skepticism and Budget Cuts with Health and Human Services Secretary Robert F. Kennedy Jr.

Read Title: Senate Appropriations Committee Hearing: Addressing Vaccine Skepticism and Budget Cuts with Health and Human Services Secretary Robert F. Kennedy Jr. on WALY Radio

Title: Senate Appropriations Committee Hearing: Addressing Vaccine Skepticism and Budget Cuts with Health and Human Services Secretary Robert F. Kennedy Jr.

[!CDATA[The upcoming Senate Appropriations Committee hearing will feature Health and Human Services Secretary Robert F. Kennedy Jr., where he is expected to address various issues, including vaccine skepticism and proposed budget cuts. President Donald Trump's budget request for the Department of Health and Human Services includes significant cuts to discretionary funding, particularly affecting key offices like the National Institutes of Health and the Centers for Disease Control and Prevention. Kennedy recently appeared before congressional committees, where he avoided questions about vaccine safety and effectiveness. During the House Appropriations Committee hearing, Kennedy hesitated when asked about vaccinating a child against measles, stating that his opinions on vaccines are irrelevant. He declined to provide advice on vaccinating against chickenpox and polio as well. Kennedy has a history of spreading misinformation about vaccines, including during measles outbreaks. The U.S. has seen over 1,000 reported measles cases this year. Senator Bill Cassidy, a physician and chair of the HELP Committee, corrected some of Kennedy's vaccine-related statements during the previous hearings. In conclusion, the upcoming Senate hearing with Health and Human Services Secretary Robert F. Kennedy Jr. is expected to delve into critical issues such as vaccine skepticism and proposed budget cuts. Kennedy's past statements on vaccines have raised concerns, particularly amid ongoing public health challenges like measles outbreaks. The discussion at the hearing will likely shed light on these contentious topics and their implications for public health policy.]]